期刊文献+

肝炎时细胞角蛋白研究的进展 被引量:1

Research progress of cytokeratin in hepatitis
下载PDF
导出
摘要 本文阐述了细胞角蛋白在肝细胞中的表述,涉及在不同类型的病毒和非病毒性肝炎时它们循环水平的改变。了解肝炎影响细胞角蛋白的机制,它将增进我们对急性和慢性炎性肝损伤复杂性的理解。 This review article elucidates that cytokeratin, commonly expressed in hepatocyte, will alter its circulating level in different viral or non-viral hepatitis. Understanding the mechanism of hepatitis impact on cytokeratin level will enhance our understanding of the complexity of acute and chronic inflammatory liver injury.
作者 王继贵
出处 《实验与检验医学》 CAS 2012年第6期525-527,530,共4页 Experimental and Laboratory Medicine
关键词 肝炎 细胞角蛋白 生物标志物 Hepatitis Cytokeratin Biomarker
  • 相关文献

参考文献24

  • 1Rosen HR. Clinical practice.Chronic hepatitis C infection[J].New England Journal of Medicine,2011,(25):2429-2438.
  • 2Karayiannis P. The detection of hepatitis viruses[J].Methods in Molecular Biology,2011.79-100.
  • 3Reshetnyak UI,Karlovich TI,Ilchenko LU. Hepatitis G virus[J].World Journal of Gastroenterology,2008,(30):4725-4734.doi:10.3748/wjg.14.4725.
  • 4Erent F,Yilmaz Y,Kose S. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B[J].Clinica Chimica Acta,2010,(23-24):2029-2032.
  • 5Bateman AC,Hubscher SG. Cytokeratin expression as an aid to diagnosis in medical liver biopsies[J].Histopathology,2010,(04):415-425.
  • 6Yilmaz Y. Systematic review:caspase-cleaved fragments of cytokeratin 18-the promises and challenges of a biomarker for chronic liver disease[J].Alimentary Pharmacology and Therapeutics,2009,(11-12):1103-1109.
  • 7Zatloukal K,French SW,Stumptner C. From Mallory to Mallory-Denk bodies:what,how and why[J].Experimental Cell Research,2007,(10):2033-2049.
  • 8Hubscher SG. Histological assessment of non-alcoholic fatty liver disease[J].Histopathology,2006,(05):450-465.doi:10.1111/j.1365-2559.2006.02416.x.
  • 9Linder S,Olofsson MH,Herrmann R. Utilization of cytokiratin-based biomarkes for pharmacodynamic study[J].Expert Review of Molecular Diagnostics,2010,(03):353-359.
  • 10Yilmaz Y,Dolsr E,Ulukaya E. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C[J].Medical Science Monitor,2009,(04):CR189-CR193.

同被引文献8

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部